Emerging Microglial Therapies and Targets in Clinical Trial

Area of Science:

• Neuroscience
• Immunology
• Drug Development

Background:

• Human genetic studies and biological evidence implicate the innate immune system, specifically microglia, in neurological dysfunction.
• Microglia's role in neuronal health is increasingly recognized, with genetic variants linked to disease risk.
• The innate immune system is a key factor in neurodegenerative and neuropsychiatric disorders.

Purpose of the Study:

• To provide an overview of emerging therapies targeting microglia function for neurological disorders.
• To highlight current clinical trials investigating microglial modulation as a therapeutic strategy.
• To explore the potential of boosting microglia's homeostatic and reparative functions.

Main Methods:

• Review of human genetic association studies linking immune-modulatory proteins in microglia to disease risk.
• Analysis of biological evidence supporting the innate immune system's causal role in neurological dysfunction.
• Examination of clinical-stage therapeutic compounds designed to modulate myeloid cell function.

Main Results:

• Identification of disease risk gene variants provides tools to assess microglia's impact on neuronal health.
• Development of clinical-stage therapeutics enables investigation into modulating microglia function.
• Emerging therapies aim to enhance microglia's beneficial homeostatic and reparative functions.

Conclusions:

• Modulating microglia function is a promising therapeutic avenue for neurodegenerative and neuropsychiatric disorders.
• Targeting microglia offers a transformational approach to mitigate neurological diseases.
• Boosting beneficial microglia functions may lead to improved patient outcomes.